TY - JOUR
T1 - Sodium-glucose cotransporter 2 inhibitors at the intersection of cardiovascular, renal and metabolic care
T2 - an integrated and multidisciplinary approach to patient-centered care
AU - Verma, Subodh
AU - Klug, Eric
AU - Mareev, Viacheslav Y.
AU - Kobalava, Zhanna D.
AU - Connelly, Kim A.
AU - Arici, Mustafa
AU - Berwanger, Otávio
AU - Santoso, Anwar
AU - Mehta, Roopa
AU - Meglis, Gus
AU - Kosiborod, Mikhail N.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - PURPOSE OF REVIEW: The management of individuals who live with type 2 diabetes requires an integrated and multifaceted approach. RECENT FINDINGS: Sodium-glucose cotransporter 2 inhibitors effectively prevent and treat cardiorenal complications in the presence of type 2 diabetes. They also reduce death and disease progression in those with established heart failure (with reduced ejection fraction) in the absence of diabetes. SUMMARY: Close collaborations between primary care physicians, cardiovascular specialists, endocrinologists and nephrologists are necessary to optimize cardiovascular, renal and metabolic risk reduction in their shared patients.
AB - PURPOSE OF REVIEW: The management of individuals who live with type 2 diabetes requires an integrated and multifaceted approach. RECENT FINDINGS: Sodium-glucose cotransporter 2 inhibitors effectively prevent and treat cardiorenal complications in the presence of type 2 diabetes. They also reduce death and disease progression in those with established heart failure (with reduced ejection fraction) in the absence of diabetes. SUMMARY: Close collaborations between primary care physicians, cardiovascular specialists, endocrinologists and nephrologists are necessary to optimize cardiovascular, renal and metabolic risk reduction in their shared patients.
UR - http://www.scopus.com/inward/record.url?scp=85089301163&partnerID=8YFLogxK
U2 - 10.1097/HCO.0000000000000774
DO - 10.1097/HCO.0000000000000774
M3 - Article
C2 - 32694262
AN - SCOPUS:85089301163
VL - 35
SP - 589
EP - 601
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
SN - 0268-4705
IS - 5
ER -